Global Short-acting GLP-1RA Market Growth 2026-2032
The global Short-acting GLP-1RA market size is predicted to grow from US$ 7373 million in 2025 to US$ 11390 million in 2032; it is expected to grow at a CAGR of 6.5% from 2026 to 2032.
Short-acting GLP-1RAs, or short-acting Glucagon-Like Peptide-1 Receptor Agonists, have a relatively shorter half-life, which is advantageous for slowing gastric emptying and, thus, better controlling post-meal blood sugar levels.
Short-acting GLP-1RA (Glucagon-Like Peptide-1 Receptor Agonist) is a class of drugs used to treat type 2 diabetes by mimicking the action of the GLP-1 hormone, leading to increased insulin secretion, decreased glucagon secretion, slowed gastric emptying, and a sense of fullness. Currently, the market share of short-acting GLP-1RA is relatively small. However, with ongoing innovation and technological advancements in the diabetes treatment field, short-acting GLP-1RA presents potential growth opportunities in the pharmaceutical market. Due to its rapid effects and more flexible administration, short-acting GLP-1RA is attractive for patients in need of more timely and personalized treatment. In the future, as medical technology continues to advance, short-acting GLP-1RA is expected to play a more significant role in diabetes treatment, providing patients with more effective medication choices.
LP Information, Inc. (LPI) ' newest research report, the “Short-acting GLP-1RA Industry Forecast” looks at past sales and reviews total world Short-acting GLP-1RA sales in 2025, providing a comprehensive analysis by region and market sector of projected Short-acting GLP-1RA sales for 2026 through 2032. With Short-acting GLP-1RA sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Short-acting GLP-1RA industry.
This Insight Report provides a comprehensive analysis of the global Short-acting GLP-1RA landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Short-acting GLP-1RA portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Short-acting GLP-1RA market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Short-acting GLP-1RA and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Short-acting GLP-1RA.
This report presents a comprehensive overview, market shares, and growth opportunities of Short-acting GLP-1RA market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Short-acting GLP-1RAs, or short-acting Glucagon-Like Peptide-1 Receptor Agonists, have a relatively shorter half-life, which is advantageous for slowing gastric emptying and, thus, better controlling post-meal blood sugar levels.
Short-acting GLP-1RA (Glucagon-Like Peptide-1 Receptor Agonist) is a class of drugs used to treat type 2 diabetes by mimicking the action of the GLP-1 hormone, leading to increased insulin secretion, decreased glucagon secretion, slowed gastric emptying, and a sense of fullness. Currently, the market share of short-acting GLP-1RA is relatively small. However, with ongoing innovation and technological advancements in the diabetes treatment field, short-acting GLP-1RA presents potential growth opportunities in the pharmaceutical market. Due to its rapid effects and more flexible administration, short-acting GLP-1RA is attractive for patients in need of more timely and personalized treatment. In the future, as medical technology continues to advance, short-acting GLP-1RA is expected to play a more significant role in diabetes treatment, providing patients with more effective medication choices.
LP Information, Inc. (LPI) ' newest research report, the “Short-acting GLP-1RA Industry Forecast” looks at past sales and reviews total world Short-acting GLP-1RA sales in 2025, providing a comprehensive analysis by region and market sector of projected Short-acting GLP-1RA sales for 2026 through 2032. With Short-acting GLP-1RA sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Short-acting GLP-1RA industry.
This Insight Report provides a comprehensive analysis of the global Short-acting GLP-1RA landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Short-acting GLP-1RA portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Short-acting GLP-1RA market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Short-acting GLP-1RA and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Short-acting GLP-1RA.
This report presents a comprehensive overview, market shares, and growth opportunities of Short-acting GLP-1RA market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Exenatide
- Beinaglutide
- Lixisenatide
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca
- Sanofi
- Shanghai Benemae Pharmaceutical
- What is the 10-year outlook for the global Short-acting GLP-1RA market?
- What factors are driving Short-acting GLP-1RA market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Short-acting GLP-1RA market opportunities vary by end market size?
- How does Short-acting GLP-1RA break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Short-acting GLP-1RA Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Short-acting GLP-1RA by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Short-acting GLP-1RA by Country/Region, 2021, 2025 & 2032
2.2 Short-acting GLP-1RA Segment by Type
2.2.1 Exenatide
2.2.2 Beinaglutide
2.2.3 Lixisenatide
2.2.4 Short-acting GLP-1RA Sales by Type
2.2.4.1 Global Short-acting GLP-1RA Sales Market Share by Type (2021-2026)
2.2.4.2 Global Short-acting GLP-1RA Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Short-acting GLP-1RA Sale Price by Type (2021-2026)
2.3 Short-acting GLP-1RA Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Short-acting GLP-1RA Sales by Application
2.3.4.1 Global Short-acting GLP-1RA Sale Market Share by Application (2021-2026)
2.3.4.2 Global Short-acting GLP-1RA Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Short-acting GLP-1RA Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Short-acting GLP-1RA Breakdown Data by Company
3.1.1 Global Short-acting GLP-1RA Annual Sales by Company (2021-2026)
3.1.2 Global Short-acting GLP-1RA Sales Market Share by Company (2021-2026)
3.2 Global Short-acting GLP-1RA Annual Revenue by Company (2021-2026)
3.2.1 Global Short-acting GLP-1RA Revenue by Company (2021-2026)
3.2.2 Global Short-acting GLP-1RA Revenue Market Share by Company (2021-2026)
3.3 Global Short-acting GLP-1RA Sale Price by Company
3.4 Key Manufacturers Short-acting GLP-1RA Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Short-acting GLP-1RA Product Location Distribution
3.4.2 Players Short-acting GLP-1RA Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SHORT-ACTING GLP-1RA BY GEOGRAPHIC REGION
4.1 World Historic Short-acting GLP-1RA Market Size by Geographic Region (2021-2026)
4.1.1 Global Short-acting GLP-1RA Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Short-acting GLP-1RA Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Short-acting GLP-1RA Market Size by Country/Region (2021-2026)
4.2.1 Global Short-acting GLP-1RA Annual Sales by Country/Region (2021-2026)
4.2.2 Global Short-acting GLP-1RA Annual Revenue by Country/Region (2021-2026)
4.3 Americas Short-acting GLP-1RA Sales Growth
4.4 APAC Short-acting GLP-1RA Sales Growth
4.5 Europe Short-acting GLP-1RA Sales Growth
4.6 Middle East & Africa Short-acting GLP-1RA Sales Growth
5 AMERICAS
5.1 Americas Short-acting GLP-1RA Sales by Country
5.1.1 Americas Short-acting GLP-1RA Sales by Country (2021-2026)
5.1.2 Americas Short-acting GLP-1RA Revenue by Country (2021-2026)
5.2 Americas Short-acting GLP-1RA Sales by Type (2021-2026)
5.3 Americas Short-acting GLP-1RA Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Short-acting GLP-1RA Sales by Region
6.1.1 APAC Short-acting GLP-1RA Sales by Region (2021-2026)
6.1.2 APAC Short-acting GLP-1RA Revenue by Region (2021-2026)
6.2 APAC Short-acting GLP-1RA Sales by Type (2021-2026)
6.3 APAC Short-acting GLP-1RA Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Short-acting GLP-1RA by Country
7.1.1 Europe Short-acting GLP-1RA Sales by Country (2021-2026)
7.1.2 Europe Short-acting GLP-1RA Revenue by Country (2021-2026)
7.2 Europe Short-acting GLP-1RA Sales by Type (2021-2026)
7.3 Europe Short-acting GLP-1RA Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Short-acting GLP-1RA by Country
8.1.1 Middle East & Africa Short-acting GLP-1RA Sales by Country (2021-2026)
8.1.2 Middle East & Africa Short-acting GLP-1RA Revenue by Country (2021-2026)
8.2 Middle East & Africa Short-acting GLP-1RA Sales by Type (2021-2026)
8.3 Middle East & Africa Short-acting GLP-1RA Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Short-acting GLP-1RA
10.3 Manufacturing Process Analysis of Short-acting GLP-1RA
10.4 Industry Chain Structure of Short-acting GLP-1RA
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Short-acting GLP-1RA Distributors
11.3 Short-acting GLP-1RA Customer
12 WORLD FORECAST REVIEW FOR SHORT-ACTING GLP-1RA BY GEOGRAPHIC REGION
12.1 Global Short-acting GLP-1RA Market Size Forecast by Region
12.1.1 Global Short-acting GLP-1RA Forecast by Region (2027-2032)
12.1.2 Global Short-acting GLP-1RA Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Short-acting GLP-1RA Forecast by Type (2027-2032)
12.7 Global Short-acting GLP-1RA Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Short-acting GLP-1RA Product Portfolios and Specifications
13.1.3 AstraZeneca Short-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Short-acting GLP-1RA Product Portfolios and Specifications
13.2.3 Sanofi Short-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Shanghai Benemae Pharmaceutical
13.3.1 Shanghai Benemae Pharmaceutical Company Information
13.3.2 Shanghai Benemae Pharmaceutical Short-acting GLP-1RA Product Portfolios and Specifications
13.3.3 Shanghai Benemae Pharmaceutical Short-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Shanghai Benemae Pharmaceutical Main Business Overview
13.3.5 Shanghai Benemae Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Short-acting GLP-1RA Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Short-acting GLP-1RA by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Short-acting GLP-1RA by Country/Region, 2021, 2025 & 2032
2.2 Short-acting GLP-1RA Segment by Type
2.2.1 Exenatide
2.2.2 Beinaglutide
2.2.3 Lixisenatide
2.2.4 Short-acting GLP-1RA Sales by Type
2.2.4.1 Global Short-acting GLP-1RA Sales Market Share by Type (2021-2026)
2.2.4.2 Global Short-acting GLP-1RA Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Short-acting GLP-1RA Sale Price by Type (2021-2026)
2.3 Short-acting GLP-1RA Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Short-acting GLP-1RA Sales by Application
2.3.4.1 Global Short-acting GLP-1RA Sale Market Share by Application (2021-2026)
2.3.4.2 Global Short-acting GLP-1RA Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Short-acting GLP-1RA Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Short-acting GLP-1RA Breakdown Data by Company
3.1.1 Global Short-acting GLP-1RA Annual Sales by Company (2021-2026)
3.1.2 Global Short-acting GLP-1RA Sales Market Share by Company (2021-2026)
3.2 Global Short-acting GLP-1RA Annual Revenue by Company (2021-2026)
3.2.1 Global Short-acting GLP-1RA Revenue by Company (2021-2026)
3.2.2 Global Short-acting GLP-1RA Revenue Market Share by Company (2021-2026)
3.3 Global Short-acting GLP-1RA Sale Price by Company
3.4 Key Manufacturers Short-acting GLP-1RA Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Short-acting GLP-1RA Product Location Distribution
3.4.2 Players Short-acting GLP-1RA Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SHORT-ACTING GLP-1RA BY GEOGRAPHIC REGION
4.1 World Historic Short-acting GLP-1RA Market Size by Geographic Region (2021-2026)
4.1.1 Global Short-acting GLP-1RA Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Short-acting GLP-1RA Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Short-acting GLP-1RA Market Size by Country/Region (2021-2026)
4.2.1 Global Short-acting GLP-1RA Annual Sales by Country/Region (2021-2026)
4.2.2 Global Short-acting GLP-1RA Annual Revenue by Country/Region (2021-2026)
4.3 Americas Short-acting GLP-1RA Sales Growth
4.4 APAC Short-acting GLP-1RA Sales Growth
4.5 Europe Short-acting GLP-1RA Sales Growth
4.6 Middle East & Africa Short-acting GLP-1RA Sales Growth
5 AMERICAS
5.1 Americas Short-acting GLP-1RA Sales by Country
5.1.1 Americas Short-acting GLP-1RA Sales by Country (2021-2026)
5.1.2 Americas Short-acting GLP-1RA Revenue by Country (2021-2026)
5.2 Americas Short-acting GLP-1RA Sales by Type (2021-2026)
5.3 Americas Short-acting GLP-1RA Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Short-acting GLP-1RA Sales by Region
6.1.1 APAC Short-acting GLP-1RA Sales by Region (2021-2026)
6.1.2 APAC Short-acting GLP-1RA Revenue by Region (2021-2026)
6.2 APAC Short-acting GLP-1RA Sales by Type (2021-2026)
6.3 APAC Short-acting GLP-1RA Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Short-acting GLP-1RA by Country
7.1.1 Europe Short-acting GLP-1RA Sales by Country (2021-2026)
7.1.2 Europe Short-acting GLP-1RA Revenue by Country (2021-2026)
7.2 Europe Short-acting GLP-1RA Sales by Type (2021-2026)
7.3 Europe Short-acting GLP-1RA Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Short-acting GLP-1RA by Country
8.1.1 Middle East & Africa Short-acting GLP-1RA Sales by Country (2021-2026)
8.1.2 Middle East & Africa Short-acting GLP-1RA Revenue by Country (2021-2026)
8.2 Middle East & Africa Short-acting GLP-1RA Sales by Type (2021-2026)
8.3 Middle East & Africa Short-acting GLP-1RA Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Short-acting GLP-1RA
10.3 Manufacturing Process Analysis of Short-acting GLP-1RA
10.4 Industry Chain Structure of Short-acting GLP-1RA
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Short-acting GLP-1RA Distributors
11.3 Short-acting GLP-1RA Customer
12 WORLD FORECAST REVIEW FOR SHORT-ACTING GLP-1RA BY GEOGRAPHIC REGION
12.1 Global Short-acting GLP-1RA Market Size Forecast by Region
12.1.1 Global Short-acting GLP-1RA Forecast by Region (2027-2032)
12.1.2 Global Short-acting GLP-1RA Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Short-acting GLP-1RA Forecast by Type (2027-2032)
12.7 Global Short-acting GLP-1RA Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Short-acting GLP-1RA Product Portfolios and Specifications
13.1.3 AstraZeneca Short-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Short-acting GLP-1RA Product Portfolios and Specifications
13.2.3 Sanofi Short-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Shanghai Benemae Pharmaceutical
13.3.1 Shanghai Benemae Pharmaceutical Company Information
13.3.2 Shanghai Benemae Pharmaceutical Short-acting GLP-1RA Product Portfolios and Specifications
13.3.3 Shanghai Benemae Pharmaceutical Short-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Shanghai Benemae Pharmaceutical Main Business Overview
13.3.5 Shanghai Benemae Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Short-acting GLP-1RA Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Short-acting GLP-1RA Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Exenatide
Table 4. Major Players of Beinaglutide
Table 5. Major Players of Lixisenatide
Table 6. Global Short-acting GLP-1RA Sales by Type (2021-2026) & (K Units)
Table 7. Global Short-acting GLP-1RA Sales Market Share by Type (2021-2026)
Table 8. Global Short-acting GLP-1RA Revenue by Type (2021-2026) & ($ million)
Table 9. Global Short-acting GLP-1RA Revenue Market Share by Type (2021-2026)
Table 10. Global Short-acting GLP-1RA Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Short-acting GLP-1RA Sale by Application (2021-2026) & (K Units)
Table 12. Global Short-acting GLP-1RA Sale Market Share by Application (2021-2026)
Table 13. Global Short-acting GLP-1RA Revenue by Application (2021-2026) & ($ million)
Table 14. Global Short-acting GLP-1RA Revenue Market Share by Application (2021-2026)
Table 15. Global Short-acting GLP-1RA Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Short-acting GLP-1RA Sales by Company (2021-2026) & (K Units)
Table 17. Global Short-acting GLP-1RA Sales Market Share by Company (2021-2026)
Table 18. Global Short-acting GLP-1RA Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Short-acting GLP-1RA Revenue Market Share by Company (2021-2026)
Table 20. Global Short-acting GLP-1RA Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Short-acting GLP-1RA Producing Area Distribution and Sales Area
Table 22. Players Short-acting GLP-1RA Products Offered
Table 23. Short-acting GLP-1RA Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Short-acting GLP-1RA Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Short-acting GLP-1RA Sales Market Share Geographic Region (2021-2026)
Table 28. Global Short-acting GLP-1RA Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Short-acting GLP-1RA Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Short-acting GLP-1RA Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Short-acting GLP-1RA Sales Market Share by Country/Region (2021-2026)
Table 32. Global Short-acting GLP-1RA Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Short-acting GLP-1RA Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Short-acting GLP-1RA Sales by Country (2021-2026) & (K Units)
Table 35. Americas Short-acting GLP-1RA Sales Market Share by Country (2021-2026)
Table 36. Americas Short-acting GLP-1RA Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Short-acting GLP-1RA Sales by Type (2021-2026) & (K Units)
Table 38. Americas Short-acting GLP-1RA Sales by Application (2021-2026) & (K Units)
Table 39. APAC Short-acting GLP-1RA Sales by Region (2021-2026) & (K Units)
Table 40. APAC Short-acting GLP-1RA Sales Market Share by Region (2021-2026)
Table 41. APAC Short-acting GLP-1RA Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Short-acting GLP-1RA Sales by Type (2021-2026) & (K Units)
Table 43. APAC Short-acting GLP-1RA Sales by Application (2021-2026) & (K Units)
Table 44. Europe Short-acting GLP-1RA Sales by Country (2021-2026) & (K Units)
Table 45. Europe Short-acting GLP-1RA Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Short-acting GLP-1RA Sales by Type (2021-2026) & (K Units)
Table 47. Europe Short-acting GLP-1RA Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Short-acting GLP-1RA Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Short-acting GLP-1RA Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Short-acting GLP-1RA Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Short-acting GLP-1RA Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Short-acting GLP-1RA
Table 53. Key Market Challenges & Risks of Short-acting GLP-1RA
Table 54. Key Industry Trends of Short-acting GLP-1RA
Table 55. Short-acting GLP-1RA Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Short-acting GLP-1RA Distributors List
Table 58. Short-acting GLP-1RA Customer List
Table 59. Global Short-acting GLP-1RA Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Short-acting GLP-1RA Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Short-acting GLP-1RA Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Short-acting GLP-1RA Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Short-acting GLP-1RA Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Short-acting GLP-1RA Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Short-acting GLP-1RA Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Short-acting GLP-1RA Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Short-acting GLP-1RA Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Short-acting GLP-1RA Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Short-acting GLP-1RA Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Short-acting GLP-1RA Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Short-acting GLP-1RA Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Short-acting GLP-1RA Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. AstraZeneca Basic Information, Short-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 74. AstraZeneca Short-acting GLP-1RA Product Portfolios and Specifications
Table 75. AstraZeneca Short-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. AstraZeneca Main Business
Table 77. AstraZeneca Latest Developments
Table 78. Sanofi Basic Information, Short-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Short-acting GLP-1RA Product Portfolios and Specifications
Table 80. Sanofi Short-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. Shanghai Benemae Pharmaceutical Basic Information, Short-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 84. Shanghai Benemae Pharmaceutical Short-acting GLP-1RA Product Portfolios and Specifications
Table 85. Shanghai Benemae Pharmaceutical Short-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Shanghai Benemae Pharmaceutical Main Business
Table 87. Shanghai Benemae Pharmaceutical Latest Developments
Table 1. Short-acting GLP-1RA Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Short-acting GLP-1RA Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Exenatide
Table 4. Major Players of Beinaglutide
Table 5. Major Players of Lixisenatide
Table 6. Global Short-acting GLP-1RA Sales by Type (2021-2026) & (K Units)
Table 7. Global Short-acting GLP-1RA Sales Market Share by Type (2021-2026)
Table 8. Global Short-acting GLP-1RA Revenue by Type (2021-2026) & ($ million)
Table 9. Global Short-acting GLP-1RA Revenue Market Share by Type (2021-2026)
Table 10. Global Short-acting GLP-1RA Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Short-acting GLP-1RA Sale by Application (2021-2026) & (K Units)
Table 12. Global Short-acting GLP-1RA Sale Market Share by Application (2021-2026)
Table 13. Global Short-acting GLP-1RA Revenue by Application (2021-2026) & ($ million)
Table 14. Global Short-acting GLP-1RA Revenue Market Share by Application (2021-2026)
Table 15. Global Short-acting GLP-1RA Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Short-acting GLP-1RA Sales by Company (2021-2026) & (K Units)
Table 17. Global Short-acting GLP-1RA Sales Market Share by Company (2021-2026)
Table 18. Global Short-acting GLP-1RA Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Short-acting GLP-1RA Revenue Market Share by Company (2021-2026)
Table 20. Global Short-acting GLP-1RA Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Short-acting GLP-1RA Producing Area Distribution and Sales Area
Table 22. Players Short-acting GLP-1RA Products Offered
Table 23. Short-acting GLP-1RA Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Short-acting GLP-1RA Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Short-acting GLP-1RA Sales Market Share Geographic Region (2021-2026)
Table 28. Global Short-acting GLP-1RA Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Short-acting GLP-1RA Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Short-acting GLP-1RA Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Short-acting GLP-1RA Sales Market Share by Country/Region (2021-2026)
Table 32. Global Short-acting GLP-1RA Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Short-acting GLP-1RA Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Short-acting GLP-1RA Sales by Country (2021-2026) & (K Units)
Table 35. Americas Short-acting GLP-1RA Sales Market Share by Country (2021-2026)
Table 36. Americas Short-acting GLP-1RA Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Short-acting GLP-1RA Sales by Type (2021-2026) & (K Units)
Table 38. Americas Short-acting GLP-1RA Sales by Application (2021-2026) & (K Units)
Table 39. APAC Short-acting GLP-1RA Sales by Region (2021-2026) & (K Units)
Table 40. APAC Short-acting GLP-1RA Sales Market Share by Region (2021-2026)
Table 41. APAC Short-acting GLP-1RA Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Short-acting GLP-1RA Sales by Type (2021-2026) & (K Units)
Table 43. APAC Short-acting GLP-1RA Sales by Application (2021-2026) & (K Units)
Table 44. Europe Short-acting GLP-1RA Sales by Country (2021-2026) & (K Units)
Table 45. Europe Short-acting GLP-1RA Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Short-acting GLP-1RA Sales by Type (2021-2026) & (K Units)
Table 47. Europe Short-acting GLP-1RA Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Short-acting GLP-1RA Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Short-acting GLP-1RA Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Short-acting GLP-1RA Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Short-acting GLP-1RA Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Short-acting GLP-1RA
Table 53. Key Market Challenges & Risks of Short-acting GLP-1RA
Table 54. Key Industry Trends of Short-acting GLP-1RA
Table 55. Short-acting GLP-1RA Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Short-acting GLP-1RA Distributors List
Table 58. Short-acting GLP-1RA Customer List
Table 59. Global Short-acting GLP-1RA Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Short-acting GLP-1RA Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Short-acting GLP-1RA Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Short-acting GLP-1RA Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Short-acting GLP-1RA Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Short-acting GLP-1RA Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Short-acting GLP-1RA Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Short-acting GLP-1RA Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Short-acting GLP-1RA Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Short-acting GLP-1RA Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Short-acting GLP-1RA Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Short-acting GLP-1RA Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Short-acting GLP-1RA Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Short-acting GLP-1RA Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. AstraZeneca Basic Information, Short-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 74. AstraZeneca Short-acting GLP-1RA Product Portfolios and Specifications
Table 75. AstraZeneca Short-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. AstraZeneca Main Business
Table 77. AstraZeneca Latest Developments
Table 78. Sanofi Basic Information, Short-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Short-acting GLP-1RA Product Portfolios and Specifications
Table 80. Sanofi Short-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. Shanghai Benemae Pharmaceutical Basic Information, Short-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 84. Shanghai Benemae Pharmaceutical Short-acting GLP-1RA Product Portfolios and Specifications
Table 85. Shanghai Benemae Pharmaceutical Short-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Shanghai Benemae Pharmaceutical Main Business
Table 87. Shanghai Benemae Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Short-acting GLP-1RA
Figure 2. Short-acting GLP-1RA Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Short-acting GLP-1RA Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Short-acting GLP-1RA Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Short-acting GLP-1RA Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Short-acting GLP-1RA Sales Market Share by Country/Region (2025)
Figure 10. Short-acting GLP-1RA Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Exenatide
Figure 12. Product Picture of Beinaglutide
Figure 13. Product Picture of Lixisenatide
Figure 14. Global Short-acting GLP-1RA Sales Market Share by Type in 2026
Figure 15. Global Short-acting GLP-1RA Revenue Market Share by Type (2021-2026)
Figure 16. Short-acting GLP-1RA Consumed in Hospital
Figure 17. Global Short-acting GLP-1RA Market: Hospital (2021-2026) & (K Units)
Figure 18. Short-acting GLP-1RA Consumed in Clinic
Figure 19. Global Short-acting GLP-1RA Market: Clinic (2021-2026) & (K Units)
Figure 20. Short-acting GLP-1RA Consumed in Other
Figure 21. Global Short-acting GLP-1RA Market: Other (2021-2026) & (K Units)
Figure 22. Global Short-acting GLP-1RA Sale Market Share by Application (2025)
Figure 23. Global Short-acting GLP-1RA Revenue Market Share by Application in 2026
Figure 24. Short-acting GLP-1RA Sales by Company in 2026 (K Units)
Figure 25. Global Short-acting GLP-1RA Sales Market Share by Company in 2026
Figure 26. Short-acting GLP-1RA Revenue by Company in 2026 ($ millions)
Figure 27. Global Short-acting GLP-1RA Revenue Market Share by Company in 2026
Figure 28. Global Short-acting GLP-1RA Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Short-acting GLP-1RA Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Short-acting GLP-1RA Sales 2021-2026 (K Units)
Figure 31. Americas Short-acting GLP-1RA Revenue 2021-2026 ($ millions)
Figure 32. APAC Short-acting GLP-1RA Sales 2021-2026 (K Units)
Figure 33. APAC Short-acting GLP-1RA Revenue 2021-2026 ($ millions)
Figure 34. Europe Short-acting GLP-1RA Sales 2021-2026 (K Units)
Figure 35. Europe Short-acting GLP-1RA Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Short-acting GLP-1RA Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Short-acting GLP-1RA Revenue 2021-2026 ($ millions)
Figure 38. Americas Short-acting GLP-1RA Sales Market Share by Country in 2026
Figure 39. Americas Short-acting GLP-1RA Revenue Market Share by Country (2021-2026)
Figure 40. Americas Short-acting GLP-1RA Sales Market Share by Type (2021-2026)
Figure 41. Americas Short-acting GLP-1RA Sales Market Share by Application (2021-2026)
Figure 42. United States Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Short-acting GLP-1RA Sales Market Share by Region in 2026
Figure 47. APAC Short-acting GLP-1RA Revenue Market Share by Region (2021-2026)
Figure 48. APAC Short-acting GLP-1RA Sales Market Share by Type (2021-2026)
Figure 49. APAC Short-acting GLP-1RA Sales Market Share by Application (2021-2026)
Figure 50. China Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 54. India Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Short-acting GLP-1RA Sales Market Share by Country in 2026
Figure 58. Europe Short-acting GLP-1RA Revenue Market Share by Country (2021-2026)
Figure 59. Europe Short-acting GLP-1RA Sales Market Share by Type (2021-2026)
Figure 60. Europe Short-acting GLP-1RA Sales Market Share by Application (2021-2026)
Figure 61. Germany Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 62. France Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Short-acting GLP-1RA Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Short-acting GLP-1RA Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Short-acting GLP-1RA Sales Market Share by Application (2021-2026)
Figure 69. Egypt Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Short-acting GLP-1RA in 2026
Figure 75. Manufacturing Process Analysis of Short-acting GLP-1RA
Figure 76. Industry Chain Structure of Short-acting GLP-1RA
Figure 77. Channels of Distribution
Figure 78. Global Short-acting GLP-1RA Sales Market Forecast by Region (2027-2032)
Figure 79. Global Short-acting GLP-1RA Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Short-acting GLP-1RA Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Short-acting GLP-1RA Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Short-acting GLP-1RA Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Short-acting GLP-1RA Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Short-acting GLP-1RA
Figure 2. Short-acting GLP-1RA Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Short-acting GLP-1RA Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Short-acting GLP-1RA Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Short-acting GLP-1RA Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Short-acting GLP-1RA Sales Market Share by Country/Region (2025)
Figure 10. Short-acting GLP-1RA Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Exenatide
Figure 12. Product Picture of Beinaglutide
Figure 13. Product Picture of Lixisenatide
Figure 14. Global Short-acting GLP-1RA Sales Market Share by Type in 2026
Figure 15. Global Short-acting GLP-1RA Revenue Market Share by Type (2021-2026)
Figure 16. Short-acting GLP-1RA Consumed in Hospital
Figure 17. Global Short-acting GLP-1RA Market: Hospital (2021-2026) & (K Units)
Figure 18. Short-acting GLP-1RA Consumed in Clinic
Figure 19. Global Short-acting GLP-1RA Market: Clinic (2021-2026) & (K Units)
Figure 20. Short-acting GLP-1RA Consumed in Other
Figure 21. Global Short-acting GLP-1RA Market: Other (2021-2026) & (K Units)
Figure 22. Global Short-acting GLP-1RA Sale Market Share by Application (2025)
Figure 23. Global Short-acting GLP-1RA Revenue Market Share by Application in 2026
Figure 24. Short-acting GLP-1RA Sales by Company in 2026 (K Units)
Figure 25. Global Short-acting GLP-1RA Sales Market Share by Company in 2026
Figure 26. Short-acting GLP-1RA Revenue by Company in 2026 ($ millions)
Figure 27. Global Short-acting GLP-1RA Revenue Market Share by Company in 2026
Figure 28. Global Short-acting GLP-1RA Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Short-acting GLP-1RA Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Short-acting GLP-1RA Sales 2021-2026 (K Units)
Figure 31. Americas Short-acting GLP-1RA Revenue 2021-2026 ($ millions)
Figure 32. APAC Short-acting GLP-1RA Sales 2021-2026 (K Units)
Figure 33. APAC Short-acting GLP-1RA Revenue 2021-2026 ($ millions)
Figure 34. Europe Short-acting GLP-1RA Sales 2021-2026 (K Units)
Figure 35. Europe Short-acting GLP-1RA Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Short-acting GLP-1RA Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Short-acting GLP-1RA Revenue 2021-2026 ($ millions)
Figure 38. Americas Short-acting GLP-1RA Sales Market Share by Country in 2026
Figure 39. Americas Short-acting GLP-1RA Revenue Market Share by Country (2021-2026)
Figure 40. Americas Short-acting GLP-1RA Sales Market Share by Type (2021-2026)
Figure 41. Americas Short-acting GLP-1RA Sales Market Share by Application (2021-2026)
Figure 42. United States Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Short-acting GLP-1RA Sales Market Share by Region in 2026
Figure 47. APAC Short-acting GLP-1RA Revenue Market Share by Region (2021-2026)
Figure 48. APAC Short-acting GLP-1RA Sales Market Share by Type (2021-2026)
Figure 49. APAC Short-acting GLP-1RA Sales Market Share by Application (2021-2026)
Figure 50. China Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 54. India Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Short-acting GLP-1RA Sales Market Share by Country in 2026
Figure 58. Europe Short-acting GLP-1RA Revenue Market Share by Country (2021-2026)
Figure 59. Europe Short-acting GLP-1RA Sales Market Share by Type (2021-2026)
Figure 60. Europe Short-acting GLP-1RA Sales Market Share by Application (2021-2026)
Figure 61. Germany Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 62. France Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Short-acting GLP-1RA Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Short-acting GLP-1RA Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Short-acting GLP-1RA Sales Market Share by Application (2021-2026)
Figure 69. Egypt Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Short-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Short-acting GLP-1RA in 2026
Figure 75. Manufacturing Process Analysis of Short-acting GLP-1RA
Figure 76. Industry Chain Structure of Short-acting GLP-1RA
Figure 77. Channels of Distribution
Figure 78. Global Short-acting GLP-1RA Sales Market Forecast by Region (2027-2032)
Figure 79. Global Short-acting GLP-1RA Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Short-acting GLP-1RA Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Short-acting GLP-1RA Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Short-acting GLP-1RA Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Short-acting GLP-1RA Revenue Market Share Forecast by Application (2027-2032)
